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Abstract: Background: Diabetes prevalence is on the increase globally and its impact on those with 
the condition in terms of acute and chronic complications can be profound. People with type 2 
diabetes constitute the majority of those with diabetes and the risk factors include obesity, lifestyle 
and gut microbiota dysbiosis. Poor dietary intake has been reported to influence the community of 
gut microbiome. Therefore, higher intake of dietary fibre may alter the environment in the gut and 
promote microbial growth and proliferation. Aim: This is a systematic review and meta-analysis 
which examined the effect of dietary fibre on gut microbiota in patients with type 2 diabetes. 
Method: This review was conducted in line with the PRISMA framework. Databases were searched 
for relevant articles which were screened based on inclusion and exclusion criteria. Results: Nine 
articles which met the inclusion criteria were selected for the systematic review and meta-analysis. 
High dietary intake significantly improved (p < 0.05) the abundance of Bifidobacterium, total SCFAs 
and HbA1c. Discussion: The promotion of SCFA producers in greater diversity and abundance by 
dietary fibre may have resulted in improvement in glycated haemoglobin, partly due to increased 
GLP–1 production. Conclusion: Consumption of high dietary fibre has significant (p < 0.05) effect 
on Bifidobacterium, total SCFAs and HbA1c, but not (p > 0.05) on propionic, butyric, and acetic acid, 
fasting blood glucose and HOMAR–IR. 
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1. Introduction 
The prevalence of type 2 diabetes is increasing worldwide, both in developed countries and in 
developing economies [1,2]. Furthermore, type 2 diabetes represents about 90% of adults who are 
diagnosed with diabetes, often associated with acute (such as hyperglycaemia, diabetic ketoacidosis, 
hyperosmolar hyperglycaemic state) and chronic complications (including kidney dysfunction, 
neuropathy, retinopathy and cardiovascular diseases) [3,4]. A range of factors such as overweight 
and obesity, lifestyle, genetic predisposition and gut microbiota dysbiosis have been implicated in 
the aetiology of type 2 diabetes [5]. In particular, low intake of dietary fibre and consumption of foods 
that are high in fat and sugar which are common in western lifestyle have been reported to contribute 
to the depletion in the abundance of specific bacteria taxa and the diversity of the gut microbial 
community [6]. Therefore, it is possible that a higher intake of dietary fibre may alter the environment 
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in the gut and provide the needed substrate for microbial bloom. Our current understanding of the 
exact relationships between gut microbiota and diseases is limited and continues to evolve [7,8]. 
While previous reviews have focused on the role of general diet on gut microbiota, the current review 
is a systematic review and meta-analysis which evaluated the role of dietary fibre in modulating gut 
microbiota dysbiosis in patients with type 2 diabetes.  
2. Method 
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was the 
framework used for this review [9]. Various electronic databases including EBSCOHost with links to 
Health Sciences Research Databases (encompassing Academic Search Premier, MEDLINE, 
Psychology and Behavioral Sciences Collection, APA PsycInfo, CINAHL Plus with Full Text and 
APA PsycArticles databases), EMBASE and Google Scholar were searched for relevant articles. The 
reference lists of articles were also searched. Searches were conducted from date of commencement 
of database to 5 August 2020. The search strategy was based on Population, Intervention, 
Comparator, Outcomes, Studies (PICOS) framework and involved the use of synonyms and medical 
subject headings (MesH). Search terms were combined with Boolean operators (OR/AND). Results 
of the searches were screened for eligibility based on inclusion and exclusion criteria. Only 
randomised controlled trials were included in the review and the studies were evaluated for quality 
and risk of bias [10]. The meta-analysis was conducted using Review Manager 5.3 software [11].  
3. Results 
Nine studies which met the inclusion criteria were selected for the systematic review and meta-
analysis and four distinct areas were identified: The effect of dietary fibre on gut microbiota; The role 
of dietary fibre on short chain fatty acids (SCFAs); Glycaemic control and Adverse events. There was 
significant improvement (p < 0.01) in the relative abundance of Bifidobacterium with a mean 
difference of 0.72 (95% CI, 0.56, 0.89) in the dietary fibre group compared with placebo (Figure 1). 
 
Figure 1. Shows the effect of dietary fibre on Bifidobacterium (%). 
In relation to the meta-analysis for SCFAs, while there was significant difference (p = 0.02) 
between the dietary fibre group and placebo with a standardised mean difference of 0.5 (95% CI, 0.08, 
0.91) regarding total SCFAs (Figure 2), the differences were not significant (p > 0.05) in relation to 
acetic acid, propionic acid and butyric acid.  
 
Figure 2. Shows the effect of dietary fibre on Total Short Chain Fatty Acids. 
There was only significant improvement (p = 0.002) with respect to glycated haemoglobin with 
a mean difference of −0.18 (95% CI, −0.29, −0.06) in the dietary fibre group compared with placebo 
group (Figure 3). Differences between the two groups were not significant (p > 0.05) in relation to 
fasting blood glucose and Homeostatic Model Assessment of Insulin Resistance (HOMAR–IR). 
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Furthermore, there were no significant differences between the two groups in subjects who reported 
adverse events.  
 
Figure 3. Shows the effect of dietary fibre on Glycated Haemoglobin (%). 
4. Discussion 
It is possible that the promotion of SCFA producers in greater diversity and abundance by 
dietary fibre in this review led to improvement in glycated haemoglobin, partly due to increased 
glucagon-like peptide-1 (GLP–1) production [12]. In addition, Bifidobacterium lactis has been 
reported to increase glycogen synthesis, decrease expression of hepatic gluconeogenesis–genes, 
improve translocation of glucose transport– 4 and promote glucose uptake [13]. It is also possible that 
the reduction in body weight of participants in the intervention group compared with control may 
have contributed to the observed improvement in glycated haemoglobin in the dietary fibre group 
[14].  
5. Conclusions 
This systematic review and meta-analysis have demonstrated that dietary fibre can significantly 
improve (p < 0.05) the relative abundance of Bifidobacterium, total SCFAs and glycated haemoglobin. 
However, dietary fibre did not appear to have significant effect (p > 0.05) on fasting blood glucose, 
HOMAR–IR, acetic acid, propionic acid, butyric acid and adverse events. 
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